Effects of SET and SET-CAN on the differentiation of the human promonocytic cell line U937
Open Access
- 4 December 2003
- journal article
- Published by Springer Nature in Leukemia
- Vol. 18 (2) , 337-340
- https://doi.org/10.1038/sj.leu.2403227
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Tumor Suppressor NM23-H1 Is a Granzyme A-Activated DNase during CTL-Mediated Apoptosis, and the Nucleosome Assembly Protein SET Is Its InhibitorCell, 2003
- The Oncoprotein Set/TAF-1β, an Inhibitor of Histone Acetyltransferase, Inhibits Active Demethylation of DNA, Integrating DNA Methylation and Transcriptional SilencingJournal of Biological Chemistry, 2002
- Regulation of Histone Acetylation and Transcription by Nuclear Protein pp32, a Subunit of the INHAT ComplexJournal of Biological Chemistry, 2002
- Novel Role for the Nuclear Phosphoprotein SET in Transcriptional Activation of P450c17 and Initiation of NeurosteroidogenesisMolecular Endocrinology, 2000
- Functional Domains of Template-Activating Factor-I as a Protein Phosphatase 2A InhibitorBiochemical and Biophysical Research Communications, 1999
- Template Activating Factor-I Remodels the Chromatin Structure and Stimulates Transcription from the Chromatin TemplateJournal of Biological Chemistry, 1998
- Cellular Localization and Expression of Template-Activating Factor I in Different Cell TypesExperimental Cell Research, 1998
- HRX Leukemic Fusion Proteins Form a Heterocomplex with the Leukemia-associated Protein SET and Protein Phosphatase 2APublished by Elsevier ,1997
- Characterization of the translocation breakpoint sequences of two DEK‐CAN fusion genes present in t(6;9) acute myeloid leukemia and a SET‐CAN fusion gene found in a case of acute undifferentiated leukemiaGenes, Chromosomes and Cancer, 1992
- The (6;9) chromosome translocation, associated with a specific subtype of acute nonlymphocytic leukemia, leads to aberrant transcription of a target gene on 9q34.Molecular and Cellular Biology, 1990